Atsushi Takayanagi - Concepedia

Author

Atsushi Takayanagi

Also Known As

A Takayanagi, A. Takayanagi, ATSUSHI TAKAYANAGI, Arno Tilles, Atsushi TAKAYANAGI, Atsushi Takayanagi, Atsushi Takayanagi (774027)

135

Publications

3.9K

Citations

H-Index

177

Concepts

All Affiliations

Keio University Tokyo Dental College Keio University Hospital Shiga University of Medical Science The University of Tokyo

About

Atsushi Takayanagi is an author at Keio University specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	34	2K
2	Natural Sciences	9	9	411
3	Public Health	5	5	85
4	Engineering	4	4	113
5	Health Sciences	3	3	67

Atsushi Takayanagi

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins Ken Ishii, Masayuki Amagai, Russell P. Hall, The Journal of Immunology	1997	480
Interleukin-22, a Member of the IL-10 Subfamily, Induces Inflammatory Responses in Colonic Subepithelial Myofibroblasts Akira Andoh, Zhuobin Zhang, Osamu Inatomi, Gastroenterology InflammationCytokineMucosal ImmunologyImmunologyImmune Regulation	2005	471
Caffeic Acid Phenethyl Ester Induces Apoptosis by Inhibition of NFκB and Activation of Fas in Human Breast Cancer MCF-7 Cells Masahiko Watabe, Keiichi Hishikawa, Atsushi Takayanagi, Journal of Biological Chemistry	2004	214
Epithelial overexpression of interleukin-32α in inflammatory bowel disease Makoto Shioya, Atsushi Nishida, Y. Yagi, Clinical & Experimental Immunology InflammationChronic Inflammatory DiseasesEpithelial Il-32alpha ExpressionCytokineAutoimmune Disease	2007	190
Renal cancer cells lacking hypoxia inducible factor (HIF)-1 expression maintain vascular endothelial growth factor expression through HIF-2 Toshiaki Shinojima, Mototsugu Oya, Atsushi Takayanagi, Carcinogenesis	2006	159
Constitutive activation of nuclear factor-κB prevents TRAIL-induced apoptosis in renal cancer cells Mototsugu Oya, Masafumi Ohtsubo, Atsushi Takayanagi, Oncogene Signaling PathwayCell RegulationConstitutive ActivationMedicineApoptosis	2001	146
Increased nuclear factor-κB activation is related to the tumor development of renal cell carcinoma Mototsugu Oya, Atsushi Takayanagi, Akio Horiguchi, Carcinogenesis Renal PathologyImmunologyPathologyCancer BiologyTumor Biology	2003	128
Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice† Kengo Tomita, Yuichi Oike, Toshiaki Teratani, Hepatology	2008	115
A novel gene delivery system using EGF receptor‐mediated endocytosis Jiabing Chen, Shinobu Gamou, Atsushi Takayanagi, FEBS Letters	1994	102
Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities Masaki Kurogochi, Masako Mori, Kenji Osumi, PLoS ONE Glycoengineered Monoclonal AntibodiesGlycobiologyImmunologyImmunotherapeuticsAnalytical Ultracentrifugation	2015	94

Page 1